66 resultados para invention
Resumo:
The present invention relates to compounds derived from taurine with non-steroidal anti inflammatory activity. In a first embodiment, the present invention relates to compounds derived from taurine, in which taurine is bound directly by means of an amide bond or through an spacing group, to a compound selected from the group of non-steroidal anti inflammatory compounds, cited as derived from taurine presenting the Formula (I): in which R means the component with non-steroidal anti inflammatory activity. In a second embodiment, the invention provides a process for obtaining the compounds of Formula (I) by reaction of taurine with a compound belonging to the group of non-steroidal anti inflammatory (NSAIs), in order to obtain a compound derived from taurine by direct bond or through a spacing group of the taurine to the NSAI. The invention also relates to the pharmaceutical compositions comprising at least one compound derived from taurine presenting non-steroidal anti inflammatory activity.
Resumo:
The present invention relates to phthalimide derivatives of non-steroidal and/or TNF-+- modulating anti-inflammatory compounds as well as the process of obtaining the so-called derivatives, pharmaceutical compositions containing such derivatives and their uses, including use in the treatment of inflammatory diseases, especially those related to chronic inflammatory processes, such as rheumatoid arthritis and intestinal inflammatory diseases (for instance, Chron's disease) and the use of the referred to pharmaceutical compositions as antipyretic, analgesic and platelet antiaggregating medications.
Resumo:
The present invention provides the use of molecules for cholinergic and/or serotonergic system models, revealing pharmaceutical compositions comprising 11-OH-erythravine, erythravine, erythrartine, pharmaceutically acceptable isotherals, salts, byproducts and/or solvates thereof, optionally containing other erythrina byproducts, for the treatment of anxiety disorders; processes for obtaining said pharmaceutical compositions are also revealed.
Resumo:
This invention relates to an apparatus and method for improving detection by equipment used to detect magnetic susceptibility. The advantages provided are related to different factors, such as reduced instrumentation cost, performance in terms of stability and sensitivity, etc. The devices may be used, for example, to detect magnetic tracers and markers in the gastrointestinal tract of animals and humans. They can be used in research and/or for diagnostic purposes using information related to a variety of parameters of the gastrointestinal tract, such as, pharyngeal and oesophageal transit time, gastric emptying and motility, colonic motility, inter alia.
Resumo:
The invention of a modified nylon mesh for structural reinforcement of dental prostheses is described, said modified nylon mesh comprising polyamide fibres and 0.3%-0.5% v/v silicon dioxide (SiO2), which enables chemical binding between the acrylic resin and the polyamide mesh in order to increase the strength of the resin/polyamide complex in said dental prosthesis.
Resumo:
The present invention discloses the use of the bacterial cellulose membrane in ligament, tendon and synovial capsule reconstructions according to the methods described in the technical description of the invention. Said material could be used in the reconstruction of ligaments and tendons (the knee cruciate ligaments, patellar ligament, Achilles tendon, quadriceps tendon, etc.) and the synovial capsule.
Resumo:
The invention described is a method for determining embryo viability and quality that makes a quick evaluation possible, with minimal interference in the development of the embryo, using a microscopy system associated with digital image capture, providing a set of values for each embryo which represents to what extent the embryo can be considered to belong to each of the four possible grades, using artificial neural network technology, with objectivity and reproducibility.
Resumo:
Contamination of Brazilian sugar-cane rum by ethyl carbamate, a potentially carcinogenic substance, is considered an obstacle to export of the beverage. Copper is involved in ethyl-carbamate-formation reactions, and the replacement thereof by stainless steel in distillation equipment, with the aim of preventing the formation of said compound, results in a beverage of poor sensory quality owing to the presence of dimethyl sulphide. A reduction in the concentration of sulphurated compounds in the final product may be achieved by the placing of a copper device (Patent No. 8206688) inside the dome of a stainless-steel alembic. It is therefore appropriate to verify the efficiency of using other forms of catalysts that, in addition to reducing ethyl-carbamate levels, are able, likewise, to trigger other catalytic actions that allow the production of a distillate of good sensory quality. Silver is the noble metal most used in industry and, on account of the catalytic properties thereof, it is ideal for use as a catalyst in oxidation reactions. The subject matter of the present invention comprises a method involving the use of silver in the distillation of alcoholic beverages, such as sugar-cane rum, which reduces ethyl-carbamate contamination of the end-product.
Resumo:
The present invention describes a method for transforming chemolithotrophic acidophilic bacteria using electroporation technology. The proposed method allows transforming a bacterial line using a transformation vector, the pAF vector, which contains an origin of vegetative replication that allows the vector to replicate inside the bacteria without altering the natural physiological functions of the latter. Also disclosed is the use of the bacteria modified according to the invention in bioleaching processes of sulphated copper, gold, uranium, nickel, zinc and cobalt ore, inter alia.
Resumo:
The invention of a process for producing synthetic melanin is described, as well as the respective product obtained. More specifically, the invention comprises aqueous synthesis of melanin by oxidation of the melanin precursor (L-DOPA) using a hydrothermal reactor.
Resumo:
The invention relates to the synthesis and characterisation of ruthenium(II) phosphine complexes containing picolinate and/or diimine and/or biphosphine ions and having an outstanding pharmacological activity for inhibiting the growth of tuberculosis mycobacteria. These complexes can first be used in the chemical industry, and in the medium and long term, in the pharmaceutical industry. The invention also describes how the activity against tuberculosis bacillus was determined, and how the toxicity of the complexes against macrophage cells within which the tuberculosis bacillus grows was assessed.
Resumo:
The present invention provides the use of molecules for cholinergic serotonergic and/or gabaergic system models, revealing pharmaceutical compositions comprising 11-OH-erythravine, erythravine, erythrartine, pharmaceutically acceptable isotherals, salts, byproducts and/or solvates thereof, optionally containing other Erythrine byproducts, for the treatment of anxiety disorders; processes for obtaining said pharmaceutical compositions...
Resumo:
The present invention describes a method for transforming chemolithotrophic acidophilic bacteria using electroporation technology. The proposed method allows transforming a bacterial line using a transformation vector, the pAF vector, which contains an origin of vegetative replication that allows the vector to replicate inside the bacteria without altering the natural physiological functions of the latter. Also disclosed is the use of the bacteria modified according to the invention in bioleaching processes of sulphated copper, gold, uranium, nickel, zinc and cobalt ore, inter alia.
Resumo:
The present invention relates to novel methods of obtaining reabsorbable composites, based on bacterial cellulose and collagen, for application in tissue repairing Additionally, the present invention relates to the composites obtained by the methods described herein and their uses.
Resumo:
Based on the reflections of Habermas and his conception of modernity, understood as an unfinished project, Giddens stresses that in all societies the maintenance of personal identity and its connection to broader social identities is a primordial requirement for ontological security. To achieve ontological security, modernity had to (re) invent traditions and get away from genuine traditions, that is, those values radically linked to the pre-modern past. This is a character of the discontinuity of modernity, the separation between what is presented as the new and that which persists as the legacy of the old. This article discusses the relationship between tradition and modernity and the dialogue between Giddens and Habermas. The goal is to identify the points of contact and the differences in the theses defended by both authors, in order to assess their contributions to discussions of the rationalization of contemporary societies. Late or reflexive modernity is an uninterrupted process of changes that affect the foundations of Western society. Faced with a reality of constant change, it is necessary to choose between the certainty of the past and a new reality of continuous change. In this sense, and according to the Habermasian perspective, the reflexive character of modernity is found in this process of choosing between the certainties inherited from the past and new social forms, a process that that leads to the reflection on - or even the recasting of - social practices, causing the rationalization and (re) invention of various aspects of life in society.